Ranked picks
This page is ingredient-first: we are not reviewing branded capsules here. We rank published entries in our database using evidence strength, safety headroom, and how far marketing runs ahead of human trials.
Ashwagandha is pinned first when it is live; the rest are nearby adaptogens and stress-adjacent picks from the same bucket so you can compare trade-offs without sales copy.
Ranked using live scores in our database - refresh cadence is editorial, not real-time.
Ashwagandha shows repeated signals for stress and sleep in human trials, yet extract standardization and safety monitoring matter.
Human trial breadth and quality
Tolerability and known risks
Marketing vs proof (higher = more hype)
Open full verdict · Scores are editorial summaries - not medical advice.
Senna is commonly associated with: occasional constipation; detox teas (problematic chronic use). Our registry tags evidence as high; this hub translates that into an ingredient-level verdict with safety and hype context - not individualized recommendations.
Human trial breadth and quality
Tolerability and known risks
Marketing vs proof (higher = more hype)
Open full verdict · Scores are editorial summaries - not medical advice.
Berberine is closer to a drug-like supplement: promising metabolic trials, but not casual candy - CYP interactions and GI effects matter.
Human trial breadth and quality
Tolerability and known risks
Marketing vs proof (higher = more hype)
Open full verdict · Scores are editorial summaries - not medical advice.
Strong interaction profile with many drugs; some depression trial support but requires clinician oversight. We summarize evidence, safety, and hype as editorial context-not medical advice.
Human trial breadth and quality
Tolerability and known risks
Marketing vs proof (higher = more hype)
Open full verdict · Scores are editorial summaries - not medical advice.
Ginger is one of the better-supported kitchen-to-capsule stories when doses are reasonable.
Human trial breadth and quality
Tolerability and known risks
Marketing vs proof (higher = more hype)
Open full verdict · Scores are editorial summaries - not medical advice.
Theanine has reasonable short-term cognition/relaxation trial signals - useful for some, not transformative for all.
Human trial breadth and quality
Tolerability and known risks
Marketing vs proof (higher = more hype)
Open full verdict · Scores are editorial summaries - not medical advice.
Chamomile is not a benzodiazepine substitute for severe anxiety.
Human trial breadth and quality
Tolerability and known risks
Marketing vs proof (higher = more hype)
Open full verdict · Scores are editorial summaries - not medical advice.
Curcumin is mechanistically interesting and sometimes clinically useful for specific pain/inflammation contexts, but it is not a universal anti-inflammatory drug replacement.
Human trial breadth and quality
Tolerability and known risks
Marketing vs proof (higher = more hype)
Open full verdict · Scores are editorial summaries - not medical advice.
We may later surface vetted product slots (forms, third-party testing notes) - always secondary to the ingredient verdicts above. Nothing here is a paid placement yet.
For picks on this page, we sort candidates by evidence score (human trial quality for common uses), then safety score, then prefer a lower hype gap when the first two tie. Pinned ingredients stay at the top so the page answers the headline before expanding context.
Numbers are not personalized risk scores and not brand QA. For the full rubric, read Methodology.
Side-by-side verdicts that touch ingredients on this leaderboard.